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The Na+/H+ exchanger isoform 1 (NHE1) is an integral membrane protein that regulates intracellular pH by extruding an intracellular H+ in
exchange for one extracellular Na+. In this study we examined the effect of site-specific mutagenesis on the pore-lining amino acid Phe161 and
effects of mutagenesis on the charged amino acids Asp159 and Asp172. There was no absolute requirement for a carboxyl side chain at amino acid
Asp159 or Asp172. Mutation of Asp159 to Asn or Gln maintained or increased the activity of the protein. Similarly, for Asp172, substitution with
a Gln residue maintained activity of the protein, even though substitution with an Asn residue was inhibitory. The Asp172Glu mutant possessed
normal activity after correction for its aberrant expression and surface targeting. Replacement of Phe161 with a Leu demonstrated that it was not
irreplaceable in NHE1 function. However, the mutation Phe161lys inhibited NHE1 function, while the Phe161Ala mutation caused altered NHE1
targeting and expression levels. Our results show that these three amino acids, while being important in NHE1 function, are not irreplaceable. This
study demonstrates that multiple substitutions at a single amino acid residue may be necessary to get a clearer picture membrane protein function.
© 2007 Elsevier B.V. All rights reserved.Keywords: Cation transport; Membrane; Na+/H+ exchanger; pH regulation1. Introduction
The Na+/H+ exchanger isoform 1 (NHE1) is a plasma mem-
brane glycoprotein that is ubiquitously expressed. It extrudes a
single intracellular proton in exchange for one extracellular
sodium ion. NHE1 thereby functions to remove excess intracel-
lular acid while facilitating Na+ entry into the cytosol [1]. The
nine known isoforms of the Na+/H+ exchanger are designated
NHE1–NHE9, named in order of their discovery [2]. NHE2–9
have more restricted tissue distributions than NHE1 and some
have predominantly intracellular localization. Mammalian
NHE1 plays a key role in regulation of cell pH, cell volume,
cell proliferation and in metastasis of some kinds of tumor cells
[1,3]. NHE1 in the myocardium is critical in mediating the
damage that occurs during ischemia/reperfusion of the heart [4–
6] and is also an important mediator of myocardial hypertrophy
[7]. Various NHE1 inhibitors are being developed for the
treatment of heart disease [8]. Of the nine isoforms, NHE1 is the⁎ Corresponding author. Tel.: +1 780 492 1848; fax: +1 780 492 0886.
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doi:10.1016/j.bbamem.2007.08.011most sensitive to NHE inhibitors and it is thought that the NHE1
inhibitor binding site may be overlapping with the sodium
binding site [9].
Although the exact mechanisms of transport and inhibitor
binding by NHE1 are not known, specific residues within se-
veral regions of the membrane domain of NHE1 have been
implicated as being important for ion binding and transport
(reviewed in [2]). Clearly one of the most important transmem-
brane segments is TM IV. Numerous residues of TM IV have
been implicated in NHE1 function. A Phe165Tyr mutation in
hamster TM IV (corresponding to human Phe161) causes both
an increase in resistance to inhibitors and a decrease in Vmax for
Na+ [10]. A Leu167Phe mutation (corresponding to human
Leu163) causes increased inhibitor resistance with no effect on
Na+ transport while a Gly174Ser mutation in TM IV causes a
modest increase in resistance to amiloride with no effect on Na+
transport [11]. Also, a Phe162Ser mutation in TM IV was found
to cause a dramatic decrease in affinity for cariporide and a 10-
fold decrease in Na+ affinity [12]. We found that both Pro167
and Pro168 of TM IV are required for normal NHE1 activity,
while Pro178, which is outside the TM region, is not [13]. In
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mutants of TM IV residues to sulfhydryl-reactive reagents and
found that the mutant Phe161Cys was significantly inhibited by
this treatment [14], demonstrating that Phe161 lines the ion
transport pore of NHE1.
We recently published the first high-resolution structure of a
transmembrane segment of the human Na+/H+ exchanger [14].
A TM IV peptide was expressed and purified, and its structure
was determined in a membrane mimetic environment. TM IV is
composed of three sections of four to nine residues that con-
verge structurally and only one region is alpha helical: Asp159-
Leu163 form a series of β-turns; Leu165-Pro168 has an ex-
tended structure; and Ile169-Pro176 forms an α-helix. Based on
our knowledge that Phe161 lines the ion transport pore, and
because the structure showed that Asp159 faces the same way
as Phe161, we decided to further investigate the importance of
these pore facing residues. We also introduced new mutations at
Asp172 [14] based on the fact that inactivity of an Asp172Cys
mutant indicated this amino acid was clearly important in
activity, and on the hypothesis that negatively charged amino
acids may be critical in coordination of transported positively
charged cations [15]. Our study provides further insights into
the mechanism of transport and further information about the
structural and functional importance of this pore-lining trans-
membrane segment of NHE1.
2. Materials and methods
2.1. Materials
Anti-HA antibody was from Santa Cruz Biotechnology (Santa Cruz, CA).
BCECF-AM was from Molecular Probes, Inc. (Eugene, OR). PWO DNA
polymerase was from Roche Molecular Biochemicals, Mannheim, Germany.
LIPOFECTAMINE™ 2000 Reagent was from Invitrogen Life Technologies,
Carlsbad, CA, USA. All other chemicals were of analytical grade and were
purchased from Fisher Scientific (Ottawa, ON), Sigma or BDH (Toronto, ON).
EMD87580 was a generous gift of Merck, Darmstadt, Germany.
2.2. Site-directed mutagenesis
The plasmid pYN4+ contains the cDNA of the entire coding region of
human NHE1 with a C-terminal hemagglutinin (HA) tag that we have pre-
viously shown does not affect activity [14]. Site-directed mutagenesis was
performed using amplification with PWO DNA polymerase followed by useTable 1
Oligonucleotide primers for site-directed mutagenesis
Mutation Primer
Asp159Asn CCCCCCTTCCTGCAaTCCa
Asp159Gln CACCCCCCTTCCTGCAaTC
Asp159Glu CCCCCCTTCCTGCAaTCCG
F161Ala CCTGCAGTCCGACGTggcC
F161Leu CCTGCAGTCCGACGTgcTC
F161Lys CTGCAGTCCGACGTgaaaTT
Asp172Asn CCGCCCATCATCCTGaATG
Asp172Gln CCGCCCATCATCCTGcAgG
Asp172Glu GCCCATCATCCTGGAgGCc
Mutated nucleotides are in lower case letters and bold. Mutated amino acid residues
endonuclease sites are underlined. In each case the forward direction of the primer pof the Stratagene (La Jolla, CA, USA) QuikChange™ site-directed muta-
genesis kit as recommended by the manufacturer. Mutations were designed
to create a new restriction enzyme site for use in screening transformants
(Table 1). Construction and initial characterization of the basic activity of the
Phe161Lys mutant was described earlier and is included here for comparative
purposes and because of the novel data found in resistance to NHE1 inhi-
bition. DNA sequencing to confirm the accuracy of the mutations and fidelity
of the product was performed by the DNA Services laboratory of the Depart-
ment of Biochemistry.
2.3. Cell culture and stable transfection
AP-1 cells are a Chinese hamster ovary cell line that lacks an endogenous
Na+/H+ exchanger. They were used to examine NHE1 activity and were rou-
tinely grown in a humidified atmosphere of 5% CO2 and 95% air in α-MEM
supplemented with 10% (v/v) bovine growth serum, 25 mM HEPES, penicillin
(100 U/ml) and streptomycin (100 μg/ml), pH 7.4 at 37 °C. The transfection and
selection of stable cell lines were carried out as described previously and
transfection was done with LIPOFECTAMINE™ 2000 Reagent [14]. Briefly,
1.3×106 cells were seeded in 100-mm Petri dish, in 8 ml of growth media. Cells
were grown until 90% confluent and transfected with 20 μg of wild-type or
mutagenized plasmids. Post-transfection cells were trypsinized, diluted 5 or 10
times with α-MEM medium and plated in 100-mm dishes in α-MEM media
containing 800 μg/ml geneticin (G418) that was used to maintain selection
pressure without acute acid load selection. After the initial selection single
clones of trasnsfected cells were obtained and stable cell lines were maintained
in 400 μg/ml G418 and were regularly re-established from frozen stocks at
passage numbers between 5 and 15. Results shown are from at least two
independently obtained clones for each mutant cell line.
2.4. SDS-PAGE and immunoblotting
For Western blot analysis equal amounts of each sample were resolved on a
9% SDS-PAGE gel and the gel was transferred onto a nitrocellulose membrane.
Immunoblot analysis with anti-HA antibody confirmed NHE1 expression in
samples from total cell lysates of transfected AP-1 cells made as described
earlier [13,16]. The Amersham enhanced chemiluminescence Western blotting
and detection system was used to detect immunoreactive proteins. Densitometric
analysis of X-ray films was carried out using NIH Image software (National
Institutes of Health, Bethesda, MD, USA).
2.5. Cell surface expression
Cell surface expression was measured as described earlier [14]. Cells were
labeled with Sulpho-NHS-SS-Biotin (Pierce Chemical Company, Rockford,
IL, USA) and immobilized streptavidin resin was used to remove surface
labeled Na+/H+ exchanger. Equal amounts of the total and unbound proteins
were analyzed by SDS-PAGE and Western blotting against the HA tag.
Relative amounts of NHE1 on the cell surface were calculated by comparingRE site
ACGTCTTCTTCCTC −PstI
CcAgGTCTTCTTCCTCTTC −PstI
AgGTCTTCTTCCTCTTC −PstI
TTCCTCTTCCTGCTG −AatII
TTCCTCTTCCTGC −AatII
CCTCTTCCTGCTG −AatII
CcGGCTACTTCCTGCC +NaeI
CcGGCTACTTCCTGCCAC +NaeI
GGCTACTTCCTGCC +NaeI
are indicated using three-letter notation and new (+) or removed (−) restriction
air is illustrated.
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2.6. Na+/H+ exchange activity
NHE1 activity was measured using a PTI Deltascan spectrofluorometer as
described earlier [17]. Stably transfected cells were seeded on glass coverslipsFig. 1. Models of the membrane domain of the NHE1 isoform of the Na+/H+ excha
illustrate its amino acid sequence. Asp159, Phe161, and Asp172, examined in the pre
structure of TM IV [14]. The side chains of Asp159, Phe161 and Asp172 are illustr(2×105 cells per coverslip) and grown until they reached 80–90% confluency.
The coverslip was then transferred to a cuvette holder with constant stirring at
37 °C. The cells were loaded with 0.15 μg/ml 2′,7-bis(2-carboxyethyl)-5 (6)
carboxyfluorescein-AM (BCECF-AM) and incubated in “Normal buffer” con-
taining 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5.5 mM
glucose, and 10 mM HEPES, pH 7.4 at 37 °C. Normal buffer is nominally
bicarbonate free and under these conditions so the contribution of bicarbonate-nger. (A) Topology of the entire membrane domain [24]. TM IV is enlarged to
sent study, are shaded. EL, extracellular loop, IL, intracellular loop. (B) Deduced
ated.
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NH3/NH4
+ prepulse/withdrawal (3 min in “Normal buffer” containing 50 mM
NH4Cl, pH 7.4), followed by withdrawal for 1–1.5 min in “Na
+-free buffer”
(135 mM N-methyl-D-glucamine, 5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2,
5.5 mM glucose, and 10 mM HEPES, pH 7.4). Intracellular pH recovery was
obtained by transferring cells to “Normal buffer” allowing the cells to recover
for at least 3 min. There were no differences in buffering capacities of stable
cell lines (not shown). Following the pHi recovery, a three-point pH calibration
curve was made using the K+/nigericin method with Na+-free calibration
buffers (135 mM N-methyl glucamine, 135 mM KCl, 1.8 mM CaCl2, 1 mM
MgSO4, 5.5 mM glucose, 10 mM HEPES, at pH 6, 7, and 8) and 10 μM
nigericin [18]. The NHE1 protein activity was determined by measuring the
slope of the first 20 s of the recovery period, which was linear and activity was
expressed as ΔpH/second. The determination of kinetic parameters of the Na+/
H+ exchanger was essentially as described earlier [18,19]. Na+ and Li+
concentrations were varied while maintaining osmolarity with N-methyl-D-
glucamine. To investigate the inhibitor sensitivity of some mutants, cells were
treated with EMD87580 of varying concentrations. EMD87580 is a highly
selective NHE1 inhibitor [20]. EMD87580 was dissolved in water and the
inhibitory effect of EMD87580 was documented using a double-pulse
acidification assay. In this assay, cells were treated with ammonium chloride
two times as described above and allowed to recover in NaCl containing
medium following each pulse. The first pulse and recovery was in the absence
of EMD87580 while the second pulse recovery was in the presence of
inhibitor. The rate of recovery from acid load was compared ±inhibitor.Fig. 2. Western blot analysis of stable cell lines expressing Asp159, Phe161 and Asp17
with HA-tagged wild-type NHE1 (NHE1) or transfected with plasmid not expressin
AP-1 cells transfected with HA-tagged wild-type NHE1 (NHE1) and the NHE1 muta
Asp172Glu, Asp172Asn, and Asp172Gln. In each lane 100 μg of total protein was
densitometric scans of the 110-kDa band relative to wild-type NHE1 for at least
Phe161Lys and Asp159Asn. Sulfo-NHS-SS-biotin-treated cells were lysed and their
bind labeled protein as described in the Materials and methods. Equal samples of total
PAGE and blotted with anti-HA antibody to identify NHE1 protein.Results are shown as mean±SE and statistical significance was determined
using a Mann–Whitney U test.
3. Results
Based on our knowledge of TM IVof the NHE1 isoform of
the Na+/H+ exchanger, we further characterized amino acids
Asp159, Phe161 and Asp172 of the transmembrane domain.
Fig. 1A illustrates a general model of the topology of TM IV.
Fig. 1B illustrates a more detailed model of the deduced struc-
ture of a TM IV peptide [14]. In this structure, amino acids
Asp159 and Phe161 were within one well-defined region of the
peptide and have side chains that project on a similar face.
However, because the peptide TM IV is not constrained by
protein–protein interactions as it would be in the full-length
NHE1, there were points of rotation in the peptide at amino
acids 164, 168 and 169. Thus, the relative position of amino
acid 172 to either 159 or 161 is uncertain.
To further study these potentially pore-lining residues in TM
IV, we made a series of mutations to amino acids Asp159,
Phe161 and Asp172 (Table 1). Both Asp159 and Asp172 were2 mutants of NHE1. (A)Western blot of cell extracts from AP-1 cells transfected
g NHE1 (AP-1). (B) Representative Western blot showing NHE1 expression in
nts Asp159Glu, Asp159Asn, Asp159Gln, Phe161Ala, Phe161Leu, Phe161Lys,
loaded. Numbers underneath the lanes indicate the mean values obtained from
three trials. (C) Subcellular localization of control NHE and TM IV mutants
proteins were solubilized and subsequently treated with streptavidin agarose to
lysates (T) and unbound (representing intracellular) lysates (I) were run on SDS-
Table 2
Plasma membrane localization of Asp159, Phe161, and Asp172 NHE1 mutants
Cell line Plasma membrane (percent of total)
NHE1 76.9±5.2
Asp159Glu 71.1±6.9
Asp159Asn 78.8±3.5
Asp159Gln 67.4±1.8
Phe161Ala 42.8±7.8 ⁎
Phe161Leu 86.3±3.0
Phe161Lys 46.6±6.4 ⁎
Asp172Glu 87.0±4.0
Asp172Asn 53.2±3.3 ⁎
Asp172Gln 62.7±1.8
Plasma membrane targeting of the Na+/H+ exchanger in AP-1 cells transfected
with wild-type NHE1 (NHE1) and with the mutants Asp159Glu, Asp159Asn,
Asp159Gln, Phe161Ala, Phe161Leu, Phe161Lys, Asp172Glu, Asp172Asn, and
Asp172Gln was determined as described in Materials and methods. The percent
of the total NHE1 protein localized to the plasma membrane is indicated. The
results are mean±standard error for at least 4 determinations.
⁎ Indicates significantly reduced plasma membrane targeting in comparison
to NHE1 (Mann–Whitney U-test, Pb0.05).
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uncharged amino acids Gln and Asn, while Phe161 was changed
to Ala, Leu and Lys. Western blotting using anti tag (HA)
antibodies was used to characterize the proteins expression
(Fig. 2). Fig. 2A shows that transfection with plasmid containing
the HA-tagged wild-type NHE1 resulted in the presence of an
immunoreactive species of 110 kDa, plus a smaller band at
95 kDa that represents an immature form of the exchanger that is
not fully glycosylated [14]. Untransfected cells or cells trans-
fected with plasmid with no insert show no such immunoreac-
tivity. A smaller, weak cross band of approximately 80 kDa in
size was often present, and its identity is not known. Fig. 2B
examined the expression levels of wild-type NHE1 and the
mutant NHE1 proteins used in this study. The amount of matureFig. 3. Na+/H+ exchanger activity of cell lines expressing control and NHE1
mutants. NHE activity was measured as described in the Materials and methods
in stable cell lines expressing NHE1. NHE1, wild-type NHE1. Mutations are
indicated below the black and hatched bars. Hatched values indicate the activity
after correction for the level of expression and surface targeting. Black bars are
uncorrected. The results are the mean± the S.E. of at least 14 determinations
from two independently made cell lines. ⁎Indicates significantly different from
the wild type at Pb0.01.110-kDaNHE1 relative to the wild-type is quantified below each
lane. All of the mutants were expressed as mostly mature NHE1
with the exception of the Phe161Lys. The Asp172Glu mutant
had substantially decreased expression of mature NHE1. For the
Phe161Lys mutant there was a substantial increase in the relative
amount of the 95-kDa protein.
We also studied the plasma membrane targeting of the mutant
NHE1 proteins. Table 2 summarizes the results and Fig. 2C
illustrates examples of the surface targeting experiments for
wild-type NHE1 and for two types of the mutant Na+/H+ ex-
changer proteins. The majority of the wild-type NHE1 protein
was present on the plasma membrane and most of the mutant
Na+/H+ exchanger proteins did not have significantly less plas-
ma membrane localization in comparison with the wild-type
protein. However, three NHE1 mutants, Phe161Ala, Phe161Lys
and Asp172Asn did have significantly reduced plasma mem-
brane targeting compared to thewild-typeNHE1 protein (Table 2
and Fig. 2C).
Once we confirmed that the Phe161, Asp159, and Asp172
mutants were at least partially expressed and targeted to the
plasma membrane, we examined the activity of the mutantFig. 4. Effect of EMD87580 on activity of control and NHE1 mutant proteins.
NHE1 activity was determined as described in the Materials and methods.
(A) Effect of 0.7 μM EMD87580 on activity of all mutants. (B) Dose depen-
dence of effects of EMD87580 on wild-type NHE1 and on the Asp172Glu and
Phe161Lys mutants.
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bars) and the activity corrected for expression and surface
processing (striped bars) relative to wild-type NHE1 for the
Phe161, Asp159, and Asp172mutants. Themutants Asp159Glu,
Asp159Asn, Phe161Ala, Phe161Lys, Asp172Glu, and
Asp172Asn had significantly decreased activity relative to
wild-type NHE1. However, after correction for expression and
plasmamembrane targeting theAsp159Asn, Phe161Ala andAsp
172Glu mutants were not significantly reduced from controls.
Surprisingly, the Asp159Gln mutant resulted in increased ex-
changer activity, and this increase in activity was not due to
increased expression and plasma membrane targeting of the
exchanger. After correction for surface targeting and expression
levels the Phe161Ala mutant was also slightly elevated in
comparison to control.
Alterations in sensitivity to inhibition have been reported
earlier upon mutation of amino acids in transmembrane seg-
ments of NHE1 [2]. EMD87580 is a potent and selective NHE1
inhibitor [20]. To determine whether alterations in NHE1 inhi-
bitor sensitivity had occurred with the amino acids mutated in
this study we initially tested the effect of 0.7 μMEMD87580 on
the mutants. We have earlier determined that this concentration
of EMD87580 inhibits approximately 50% of the activity of theFig. 5. Effect of varying Na+ and Li+ concentration on activity of control and
NHE1 mutant proteins. NHE1 activity was determined as described in the
Materials and methods. (A) Effect of varying Na+ concentration on NHE1
activity. (B) Effect of varying Li+ concentration on NHE1 activity.NHE1 protein [17]. Fig. 4A shows the results. Most of the
mutants had no apparent change in the level of inhibition in
comparison to the wild type. However the Asp172Glu mutant
appeared to be somewhat more sensitive to inhibition. The
Phe161Lys mutant showed a slight change in resistance to
inhibition, though this was small and variable. To further inves-
tigate these results these two mutants were examined in detail
along with the control. The results are shown in Fig. 4B. Wild-
type NHE1 and the Phe161Lys mutant were affected to the
same extent by EMD87580 with IC50s of 0.70 and 0.69 μM
respectively. The sensitivity of the Asp172Glu mutant was
increased and it had an IC50 of 0.24 μM.
We characterized several of the mutants in more detail to gain
insights into the nature of the effects of the mutations. The
activity of the wild-type NHE1 protein and of the mutants
Asp159Asn, Phe161Lys and Asp172Glu was examined in the
presence of varying amounts of Na+ or Li+. Fig. 5A illustrates
the effects of altering the Na+ levels on the activity of the protein.
The Asp159Gln mutant had greater activity than the wild type,
as suggested by the results of Fig. 3. The Phe161Lys and Asp
172Gln mutants had much lower activities than the wild type.
The Vmax values of the wild-type and Asp159Gln, Phe161Lys
and Asp172Glu mutants were 0.018, 0.034, 0.004 and 0.004
ΔpH/second respectively. The Km for these proteins was 58, 95,
29 and 60 mM respectively. It appeared as though the Asp159
Gln mutant was not at maximal activity even in the presence of
135 mM NaCl. Unfortunately, because higher osmotic concen-
trations are known to activate the NHE1 protein and cause
osmotic effects on the cells, we were unable to use higher NaCl
concentrations. Similar experiments were done using LiCl
instead of NaCl (Fig. 5B). In this case the data did not fit as well
to a curve fitting equation (not shown). Nevertheless, the Vmax
for the Asp159Gln mutant was elevated and the calculated Km
was again increased. It was noted that for the wild-type NHE1
protein the LiCl concentrations of 20 mM were saturating and
further increases in LiCl did not stimulate NHE1 activity further.
It has been previously reported that lower concentrations of LiCl
are required for activation of NHE1 in comparison to NaCl
concentrations [21].
4. Discussion
Transmembrane segment IV of the NHE1 isoform of the
Na+/H+ exchanger has been implicated as being critical in the
function of the protein. Through site-specific mutagenesis a
variety of the amino acids of TM IV have been shown to be
critical to NHE1 function [2]. Mutations of TM IV sometimes
alter Na+ affinity and sensitivity to inhibitors [2,11]. We re-
cently deduced the structure of a TM IV peptide and used
cysteine scanning mutagenesis to show that amino acid Phe161
lines the ion transport pore of the protein. Based on the structure
of TM IV, amino acid Asp159 is a likely candidate for facing the
transport pore of NHE1 [14]. We have also earlier suggested
that negatively charged amino acids may be critical in coor-
dination of the positive cations that are transported [15]. In the
present study we therefore further characterized Phe161 and
two acidic residues, Asp159 and Asp172.
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same general direction as Phe161, albeit with approximately a
20–30° difference in its orientation. Asp159 was examined by
changing it to Glu, Asn and Gln. The Glu mutation maintains
the negative charge with an increase in the side chain length. In
this case there was a significant decrease in activity of the
protein. When the mutation was to the uncharged residue Asn,
this mutant retained normal activity. These results indicated that
conservation of the charge of this residue was not necessary for
activity of the NHE1 protein. Surprisingly, when we mutated
Asp159 to Gln, the maximum velocity of the NHE1 protein was
increased though the mutation did not alter the resistance to
EMD87580. These results suggest that amino acid Asp159 is
important in TM IV, but that an absolute conservation of the side
chain is not necessary. It is clear that the size of the side chain
was important. The larger side chains of Glu and Gln both
affected activity dramatically while a change to Asn had little
effect. It is possible that the presence of the larger more pro-
truding negative side chain of Glu interacts with a cation to
impede its progression along the pore. A change from Asp to the
neutral residue Gln might not be so intrusive to the passage of a
cation. It is conceivable that the uncharged side chain of Gln, as
compared to the carboxyl of Asp, allows a dissociation of a
coordinated cation more quickly thereby enhancing activity.
However, further experiments are necessary to support this
suggestion. We previously showed that mutation to Cys virtual-
ly eliminated activity of this mutant [14]. It is therefore clear
that the nature of the change in the side chain is critical for
NHE1 function. It is also possible that the side chain does not
function directly in cation coordination. It could be involved in
transmembrane segment packing and helix–helix interactions.
Nevertheless, it is clear that this amino acid and side chain are
important in NHE1 function.
Mutation of Asp172 had varying effects when changed to
Glu, Gln or Asn. Simply removing the charge and changing to
Asn had an inhibitory effect. However, mutation to Gln did not
inhibit protein activity and the change to Glu also did not affect
activity when correcting for expression levels of the protein.
Therefore, removal of the charged residue was inhibitory, but
replacement with a larger residue either charged or uncharged
was not. Therefore, similar to Asp159, this amino acid residue is
important in function, but there is not an absolute requirement
for this amino acid or this side chain. It was interesting that the
Asp172Glu mutant was more sensitive to inhibition by
EMD87580. A relationship has been suggested between the
sodium binding site and the site of binding of inhibitors of NHE1
although the site of inhibitor binding is not necessarily the same
as the Na+ binding site [2,9].
In the case of Phe161 we previously showed that the Phe
161Cys mutant was impaired in activity but was not inactive
[14]. A previous study also found that mutation of Phe165Tyr in
hamster NHE1 (corresponding to Phe161 in the human se-
quence) caused a 4-fold decrease in the rate of Na+ transport
[22]. Our present results showed that mutation to the smaller
Ala residue resulted in a large decrease in activity that was due
to a combination of effects on surface targeting and expression
levels. Substitution with the hydrophobic but relatively largeLeu residue had little effect on activity but substitution with a
positively charged lysine had a large inhibitory effect on activity
independent of effects on expression and targeting. This effect
did not modify the sensitivity to EMD87580. These results
support the critical role for this residue in NHE1 function. The
inhibitory effect of a positively charged Lys at this position
could be due to a side chain providing repulsion to cations in the
transport pore. It was interesting that mutation to Leu had little
effect, while mutation to Ala affected both targeting and ex-
pression levels. It may be that alanine affected targeting and
expression because a minimum size is required to maintain
stability of the protein. When we corrected for effects of the Ala
mutation on targeting and expression, the activity was actually
slightly elevated, indicating that the protein itself was func-
tional. Overall, these results confirm that Phe161 is involved in
NHE1 function but that similar to Asp159 and Asp172, the Phe
side chain itself is not critical for activity and can be substituted
for by some amino acids.
It is interesting that the Phe161Lys mutant was largely ex-
pressed as an inactive protein that was mostly in a deglycosy-
lated form. We have earlier found this same phenomenon with
other mutants when we mutated Asp159, Phe161, Phe162,
Pro167, Pro168 and Leu171 in TM IV to cysteine [14]. In
addition both Ala and Gln mutations of Glu262 of TM VII
caused the same phenomenon [17]. The effect is specific to the
type of mutation since mutation of Phe161 to Ala or Leu did not
cause this effect. What is the cause of this? At present this is not
clear. However, we speculate that some disruption or alteration
of the transmembrane structure may be involved. This could be
caused by a disruption of direct interactions between transmem-
brane segments by the altered the side chain. Alternatively, this
could occur more indirectly as a result of disruption of an
association with the pore-lining residues of the transporter. The
propensity for various amino acids to pack in transmembrane
segments has been examined. In this regard, it is worth note that
Lys has a low packing value in alpha helices compared to Phe
[23], which could theoretically account for the effect of the
Phe161Lys mutation. However, because residue 161 was shown
to be a pore-lining residue, and because this region of TM IVwas
demonstrated to not be an alpha helix [14], this explanation may
not be plausible. It is interesting however that Ala and Leu have
higher packing values than Lys, andmutation of Phe161 to either
residue did not inhibit NHE1 activity.
Overall, it seems clear that Asp159, Phe161 and Asp172 are
critical to NHE1 function, but effects of mutation of these amino
acids varied. In all cases, substitutions could be made that
retained NHE1 activity. For Asp159 and Asp172, conservation
of the charged side chain was not essential. It is therefore clear
that either the carboxyl of these amino acids does not directly
coordinate a cation, or that there is enough redundancy in the
cation coordination so that their mutation does not have a severe
detrimental effect.
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